KR860001367B1 - 페니실란산 에스테르류의 제조 방법 - Google Patents
페니실란산 에스테르류의 제조 방법 Download PDFInfo
- Publication number
- KR860001367B1 KR860001367B1 KR8201221A KR820001221A KR860001367B1 KR 860001367 B1 KR860001367 B1 KR 860001367B1 KR 8201221 A KR8201221 A KR 8201221A KR 820001221 A KR820001221 A KR 820001221A KR 860001367 B1 KR860001367 B1 KR 860001367B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- reaction
- beta
- hydrogen atom
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical class OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 title 1
- -1 azido, amino, carbenzyloxyamino Chemical group 0.000 claims description 20
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- FUJWCOAVQJPXES-UHFFFAOYSA-N [I].CCl Chemical compound [I].CCl FUJWCOAVQJPXES-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 239000000047 product Substances 0.000 description 16
- 239000002253 acid Substances 0.000 description 14
- PJGJQVRXEUVAFT-UHFFFAOYSA-N chloroiodomethane Chemical compound ClCI PJGJQVRXEUVAFT-UHFFFAOYSA-N 0.000 description 14
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 150000003457 sulfones Chemical class 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 8
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 8
- 239000002132 β-lactam antibiotic Substances 0.000 description 8
- 229940124586 β-lactam antibiotics Drugs 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical class CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 6
- 239000003781 beta lactamase inhibitor Substances 0.000 description 5
- 229940126813 beta-lactamase inhibitor Drugs 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 102000006635 beta-lactamase Human genes 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108090000204 Dipeptidase 1 Proteins 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 125000004970 halomethyl group Chemical group 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZXUCBXRTRRIBSO-UHFFFAOYSA-L tetrabutylazanium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC ZXUCBXRTRRIBSO-UHFFFAOYSA-L 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
- 150000004684 trihydrates Chemical class 0.000 description 2
- 0 **(CC1N=*C1)C1=CC=C(*)CC1 Chemical compound **(CC1N=*C1)C1=CC=C(*)CC1 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- MGUNVFIPEPSPMZ-UHFFFAOYSA-N NC(C(=O)NC1=CC=CC=C1[SiH3])C1=CC=CC=C1 Chemical compound NC(C(=O)NC1=CC=CC=C1[SiH3])C1=CC=CC=C1 MGUNVFIPEPSPMZ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004517 catalytic hydrocracking Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- VHHHONWQHHHLTI-UHFFFAOYSA-N hexachloroethane Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)Cl VHHHONWQHHHLTI-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- ZMYZSVHJWGNTFT-UHFFFAOYSA-N hydroxy-oxo-phenylsilane Chemical compound O[Si](=O)C1=CC=CC=C1 ZMYZSVHJWGNTFT-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical class C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- LPSKDVINWQNWFE-UHFFFAOYSA-M tetrapropylazanium;hydroxide Chemical compound [OH-].CCC[N+](CCC)(CCC)CCC LPSKDVINWQNWFE-UHFFFAOYSA-M 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019860004086A KR860001369B1 (ko) | 1981-03-23 | 1986-05-24 | 페니실란산 에스테르류의 제조 방법 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24648281A | 1981-03-23 | 1981-03-23 | |
| US246,482 | 1981-03-23 | ||
| US06/341,081 US4381263A (en) | 1981-03-23 | 1982-01-25 | Process for the preparation of penicillanic acid esters |
| US341,081 | 1982-01-25 | ||
| US341081 | 1982-01-25 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019860004086A Division KR860001369B1 (ko) | 1981-03-23 | 1986-05-24 | 페니실란산 에스테르류의 제조 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR830009111A KR830009111A (ko) | 1983-12-17 |
| KR860001367B1 true KR860001367B1 (ko) | 1986-09-17 |
Family
ID=26938011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR8201221A Expired KR860001367B1 (ko) | 1981-03-23 | 1982-03-22 | 페니실란산 에스테르류의 제조 방법 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4381263A (enExample) |
| EP (1) | EP0061284B1 (enExample) |
| KR (1) | KR860001367B1 (enExample) |
| AU (1) | AU535417B2 (enExample) |
| BG (2) | BG38938A3 (enExample) |
| CA (1) | CA1182107A (enExample) |
| CS (1) | CS228920B2 (enExample) |
| DD (2) | DD202435A5 (enExample) |
| DE (1) | DE3270720D1 (enExample) |
| DK (1) | DK161969C (enExample) |
| EG (1) | EG15908A (enExample) |
| ES (2) | ES8305771A1 (enExample) |
| FI (1) | FI75165C (enExample) |
| GB (1) | GB2095665A (enExample) |
| GR (1) | GR75939B (enExample) |
| HU (1) | HU189124B (enExample) |
| IE (1) | IE52813B1 (enExample) |
| IL (1) | IL65309A (enExample) |
| IN (1) | IN157712B (enExample) |
| MX (1) | MX174205B (enExample) |
| NO (2) | NO164598C (enExample) |
| NZ (1) | NZ200067A (enExample) |
| PH (2) | PH18608A (enExample) |
| PL (1) | PL130866B1 (enExample) |
| PT (1) | PT74622B (enExample) |
| RO (2) | RO87039B1 (enExample) |
| YU (2) | YU42762B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704456A (en) * | 1985-11-22 | 1987-11-03 | Pfizer Inc. | Process for sultamicillin intermediate |
| JPH01139584A (ja) * | 1987-11-25 | 1989-06-01 | Yoshitomi Pharmaceut Ind Ltd | ペニシラン酸化合物の製造法 |
| GB8808701D0 (en) * | 1988-04-13 | 1988-05-18 | Erba Carlo Spa | Beta-lactam derivatives |
| WO1991016326A1 (en) * | 1990-04-13 | 1991-10-31 | Pfizer Inc. | Process for sultamicillin intermediate |
| ES2161602B1 (es) * | 1999-04-08 | 2003-02-16 | Asturpharma S A | Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina. |
| RU2167162C1 (ru) * | 2000-02-28 | 2001-05-20 | Савельев Евгений Александрович | Способ получения гидроиодида диэтиламиноэтилового эфира бензилпенициллина |
| CN100384857C (zh) * | 2003-11-28 | 2008-04-30 | 浙江永宁制药厂 | 耐β-内酰胺酶的头孢菌素酯化合物及其盐 |
| CN112724162B (zh) * | 2020-12-28 | 2022-06-10 | 华南农业大学 | 一种阿莫西林-舒巴坦杂合分子的合成方法及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5248992B1 (enExample) * | 1971-07-08 | 1977-12-14 | ||
| US4234579A (en) * | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
| ZA80796B (en) | 1979-02-13 | 1981-02-25 | Leo Pharm Prod Ltd | Chemical compounds |
| IE49880B1 (en) | 1979-02-13 | 1986-01-08 | Leo Pharm Prod Ltd | Penicillin derivatives |
| US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
| IE50650B1 (en) * | 1979-10-11 | 1986-06-11 | Leo Pharm Prod Ltd | Method for producing penicillanic acid derivatives |
-
1982
- 1982-01-25 US US06/341,081 patent/US4381263A/en not_active Expired - Lifetime
- 1982-02-16 IN IN127/DEL/82A patent/IN157712B/en unknown
- 1982-03-15 BG BG055783A patent/BG38938A3/xx unknown
- 1982-03-15 BG BG068275A patent/BG38940A3/xx unknown
- 1982-03-16 EP EP82301323A patent/EP0061284B1/en not_active Expired
- 1982-03-16 GB GB8207651A patent/GB2095665A/en active Pending
- 1982-03-16 DE DE8282301323T patent/DE3270720D1/de not_active Expired
- 1982-03-18 GR GR67645A patent/GR75939B/el unknown
- 1982-03-19 DD DD82238309A patent/DD202435A5/de not_active IP Right Cessation
- 1982-03-19 DD DD82251832A patent/DD209835A5/de not_active IP Right Cessation
- 1982-03-19 NZ NZ200067A patent/NZ200067A/en unknown
- 1982-03-21 EG EG147/82A patent/EG15908A/xx active
- 1982-03-22 YU YU621/82A patent/YU42762B/xx unknown
- 1982-03-22 NO NO820924A patent/NO164598C/no not_active IP Right Cessation
- 1982-03-22 RO RO112622A patent/RO87039B1/ro unknown
- 1982-03-22 PH PH27038A patent/PH18608A/en unknown
- 1982-03-22 DK DK127282A patent/DK161969C/da not_active IP Right Cessation
- 1982-03-22 PT PT74622A patent/PT74622B/pt unknown
- 1982-03-22 AU AU81765/82A patent/AU535417B2/en not_active Expired
- 1982-03-22 KR KR8201221A patent/KR860001367B1/ko not_active Expired
- 1982-03-22 CA CA000398978A patent/CA1182107A/en not_active Expired
- 1982-03-22 MX MX005355A patent/MX174205B/es unknown
- 1982-03-22 ES ES510658A patent/ES8305771A1/es not_active Expired
- 1982-03-22 FI FI820993A patent/FI75165C/fi not_active IP Right Cessation
- 1982-03-22 RO RO106987A patent/RO83707B/ro unknown
- 1982-03-22 IE IE658/82A patent/IE52813B1/en unknown
- 1982-03-22 IL IL65309A patent/IL65309A/xx not_active IP Right Cessation
- 1982-03-22 HU HU82853A patent/HU189124B/hu unknown
- 1982-03-23 CS CS822015A patent/CS228920B2/cs unknown
- 1982-03-23 PL PL1982235577A patent/PL130866B1/pl unknown
-
1983
- 1983-01-17 ES ES519053A patent/ES519053A0/es active Granted
- 1983-03-24 NO NO831057A patent/NO831057L/no unknown
- 1983-10-06 PH PH29662A patent/PH18487A/en unknown
-
1984
- 1984-09-21 YU YU1629/84A patent/YU42904B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1037949A (en) | Cephalosporin derivatives | |
| CS203927B2 (en) | Process for preparing 1-oxadethiacephalosporines | |
| KR860001367B1 (ko) | 페니실란산 에스테르류의 제조 방법 | |
| EP0039086B1 (en) | Novel ampicillin esters and production thereof | |
| JPS6124396B2 (enExample) | ||
| EP1228074B1 (en) | Method of preparing highly pure cefpodoxime proxetil | |
| US3549628A (en) | Side chain cleavage in desacetoxycephalosporin esters | |
| CS228919B2 (en) | Method of preparing halogenomethylester of 1,1-dioxide of penicillanic acid | |
| ES2300147T3 (es) | Procedimiento de preparacion de un compuesto 3-cefem. | |
| KR0148488B1 (ko) | 3-플루오로술포닐록시세프-3-엠 치환방법 | |
| SU1277897A3 (ru) | Способ получени 1,1-диоксо-6-бром(или-6,6-дибром)пеницилланоилоксиметиловых эфиров 6-(2-азидо-2-фенилацетамидо)пенициллановой кислоты | |
| US3996236A (en) | Methoxymethyl D-6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillanate | |
| US4066664A (en) | Intermediates for preparing α-carboxy-α-(3-thienyl)penicillin and cephalosporin derivatives | |
| KR860001369B1 (ko) | 페니실란산 에스테르류의 제조 방법 | |
| US3586667A (en) | Penicillin esterification process | |
| DK159155B (da) | Fremgangsmaade til fremstilling af 3-karbamoyloxymetylcephalosporinforbindelser | |
| US3971776A (en) | Thio-β-lactam penicillins | |
| US4175076A (en) | Azetidinone mercury sulfides and process therefor | |
| HU196412B (en) | Process for production of penicillin-acid-penicillakiroloximethil-esthers | |
| CA1184898A (en) | Process for the preparation of penicillanic acid esters | |
| EP0122002A1 (en) | Process for preparing azetidinone derivatives | |
| JPS63211289A (ja) | スルタミシリン及び同族体製造用中間体 | |
| JPS62212391A (ja) | セフエムアルコキシ基の脱離法 | |
| CS228948B2 (cs) | Způsob výroby penicilanoyloxymethylderivátů 1,1-dioxidu penicilanové kyseliny | |
| KR19980077157A (ko) | 세펨 유도체 제조용 중간체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19820322 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19851014 Patent event code: PE09021S01D |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19860324 Patent event code: PE09021S01D |
|
| PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19860820 |
|
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19861126 |
|
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19861203 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19861203 End annual number: 3 Start annual number: 1 |
|
| PR1001 | Payment of annual fee |
Payment date: 19890831 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 19900829 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 19910828 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 19920618 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 19930610 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 19940615 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 19950522 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 19960523 Start annual number: 11 End annual number: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 19970526 Start annual number: 12 End annual number: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 19980515 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 19990622 Start annual number: 14 End annual number: 14 |
|
| PR1001 | Payment of annual fee |
Payment date: 20000516 Start annual number: 15 End annual number: 15 |
|
| PR1001 | Payment of annual fee |
Payment date: 20010616 Start annual number: 16 End annual number: 16 |
|
| PC1801 | Expiration of term |